Dr. Raffaele Califano On Immunotherapy In Small Cell Lung Cancer

Dr. Raffaele Califano on Immunotherapy in Small Cell Lung Cancer

Raffaele Califano, ESMO 2018 – Mechanisms of resistance in non-small cell lung cancer

Touch Medical Media

Expert comment: CASPIAN trial of durvalumab in SCLC | Raffaele Califano

Medicine Matters oncology

The Investigation of Immune Checkpoint Blockades in Small Cell Lung Cancer

Targeted Oncology

Extending durvalumab maintenance to special populations

Immunotherapy for Patients with Small-Cell Lung Cancer

Dr. Sabari on Immunotherapy Updates in Small Cell Lung Cancer

Raffaele Califano, ESMO 2019 - FLAURA study in NSCLC

Touch Medical Media

DEDICATION-1: reduced versus standard dose pembrolizumab in stage IV NSCLC

Immunotherapy Treatments for Small Cell Lung Cancer (SCLC)

You and Lung Cancer

New drugs for the treatment of advanced melanoma

Dr. Bunn on Immunotherapy Advances in Small Cell Lung Cancer

MAHSC Inaugural Lectures: Professor Raffaele Califano

Health Innovation Manchester

A need for continued research with immunotherapy in small cell lung cancer: 2022 ESMO Florida

Total Health | Oncology

Immunotherapy for Small Cell Lung Cancer

GRACE - Global Resource for Advancing Cancer Education

Dr. Kosari on Antitumor Immunity in Small Cell Lung Cancer

Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC)

You and Lung Cancer

Small cell lung cancer may respond to combination of immunotherapy and targeted therapy

MD Anderson Cancer Center

Dr. Charles Rudin: Immunotherapy for Small Cell Lung Cancer

Lung Cancer Foundation of America

Dr. Bunn on the Response of Immunotherapy in Lung Cancer